Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

140.99
Delayed Data
As of 4:00pm ET
 -1.59 / -1.12%
Today’s Change
124.16
Today|||52-Week Range
208.88
-26.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues1.1B1.5B2.2B2.5B
 
 
 
 
 
Cost of Goods Sold126.2M168.4M179.0M189.4M
 
 
 
 
 
Depreciation And Amortization23.9M27.3M46.9M160.2M
 
 
 
 
 
 
Operating ExpensesGross Income971.1M1.3B2.0B2.1B
 
 
 
 
 
General Expenses583.9M779.9M1.1B1.6B
 
 
 
 
 
Research And Development215.6M307.0M499.7M709.5M
 
 
 
 
 
Total Operating Expenses734.0M975.6M1.3B1.9B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income387.2M536.4M891.9M564.4M
 
 
 
 
 
Extraordinary Credit56.9M8.3M34.2M0.00
 
 
 
 
Extraordinary Charge-49.1M-47.7M-47.2M-145.6M
 
 
 
 
 
Interest Expense On Debt7.4M4.1M3.0M47.7M
 
 
 
 
 
Other Expenses8.1M30.0M-12.2M118.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income397.6M526.3M872.1M498.1M
 
 
 
 
 
Income Taxes-142.7M-273.4M-215.2M-353.8M
 
 
 
 
 
Net Income254.8M252.9M656.9M144.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS190.5M195.5M198.1M213.4M
 
 
 
 
 
Shares To Calculate EPS Diluted198.5M199.7M201.6M215.9M
 
 
 
 
 
 
Earnings Per ShareEPS$1.28$1.27$3.26$0.67
 
 
 
 
 
EPS Diluted$1.28$1.27$3.26$0.67